Home > Result Summaries: Compounds > Haemophilus influenzae Type b Vaccine > Result Summary for 759346/009

Result Summary for 759346/009

Result Summary

Protocol ID:	759346/009
Clinical Study ID:	759346/009
Official Title:	Study to evaluate immunogenicity, reactogenicity and safety of investigational vaccination regimen as compared to GSK Bio’s Hiberix vaccine, extemporaneously mixed with GSK Bio’s Tritanrix-HepB, when administered intramuscularly in infants at 6, 10 and 14 weeks of age
Phase:	phase 2
Study Indications or Diseases:	Hib
Generic Name:	Haemophilus influenzae Type b Vaccine
Trade/Product Name:	Hiberix
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Hodgson A et al. (2008) A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana. PLoS One. 3(5):e2159.